Assertion: cirrhosis | /r/HasProperty | randomized to 12 weeks of sofosbuvir
Facets:
Source sentences:
text: CTP class C (20%) cirrhosis, 102 patients with genotype 1, 2, or 3 were randomized to 12 weeks of sofosbuvir/velpatasvir with or without ribavirin (Takehara, 2019).